The US Department of Health and Human Services – the overseer of the Food and Drug Administration and 27 other agencies and offices – is pushing back on suggestions that HHS secretary Alex Azar’s recent move to exert control over regulations was a power play aimed at the FDA.
The effort is part of a larger struggle over FDA’s reputation, with former commissioner Scott Gottlieb playing multiple roles in the drama, including penning a
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?